中文

亨迪药业 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-23
ItemAmountY/Y
Revenue¥0.12B+5.0%
Gross profit¥0.03B
Operating income¥0.01B
Net income¥0.01B-10.7%
Gross margin20.9%Net margin 7.7%
Revenue Q/Q-10.6%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.10B79.1%
R&D¥0.01B4.6%
SG&A¥0.02B13.8%
Tax & other¥0.00B0.9%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

联盛化学观想科技中汽股份万凯新材铜冠铜箔华是科技腾远钴业亚香股份光庭信息浙江恒威中荣股份恒勃股份

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies